HIGHLIGHTS


logo

Travecta Therapeutics Appoints Douglas C. Hicks as Chief Business Officer

Travecta Therapeutics, an emerging biotech company developing a platform that leverages its proprietary knowledge of the MFSD2a Transport for the targeted delivery of therapeutic agents across the blood-brain barrier, announces it has appointed Douglas C. Hicks as Chief Business Officer.

logo

Duke-NUS Business School: Critical role of DHA on foetal brain development revealed

DHA fatty acids have long been considered beneficial to the brain, but experts are not sure how it is absorbed by the brain. Local researchers unraveled the puzzle and found that the body needs an activated fatty acid and a protein to promote brain development.


logo

Mobile App Will Transform Data Entry And Collection In Clinical Studies, Company Says

ObvioHealth announced this week the launching of ClaimIt™ - a mobile application that the company says is poised to transform clinical studies globally.

logo

The cost to see from here to the horizon

Landscapes can be analyzed from either a disease or therapeutic focus...


logo

Singapore healthcare start-up ObvioHealth raises US$3m Series funding

ObvioHealth, a Singapore and Orlando-based company offering mobile and "site-less" clinical trials, said on Friday (March 23) it has raised US$3 million in Series A funding.

logo

Tackling the blood-brain barrier: Duke-NUS discovery leads to startup Travecta

Travecta Therapeutics Pte Ltd. is the latest startup to join Singapore’s biotech block.


logo

SPRIM and Tikehau Capital join forces

LIFE science startups hoping for a big break can now look to a new Singapore-based cash cow for funding.

logo

Duke-NUS commercializes discovery to deliver therapeutics across blood brain barrier

Intellectual property (IP) derived from discoveries made at Duke-NUS Medical School have been licensed to a newly formed biotech start-up...


logo

D4HLAB

Building and launching projects to transform healthcare with data, machine learning and AI.

logo

Scientific Study Shows Milk with Only the A2 Beta Casein Protein Type Reduced Acute Gastrointestinal Symptoms in Milk Sensitive Participants

Results suggest that the elimination of A1 beta casein from the diet was associated with reduced severity of acute gastrointestinal symptoms after milk intake in this population.


logo

Evid Science Receives Seed Capital to Advance Clinical AI Platform

Evid Science, an artificial intelligence (AI) company for the pharmaceutical industry, has successfully secured seed funding from TKSI...


logo

3 Ways Mobile Clinical Trials Help Clinical Researchers Improve Diversity

Lack of diversity within the clinical trial industry poses a grave problem. We cannot assume medicines work similarly across ethnicities. While attracting and retaining minority groups to participate in clinical trials has become a primary focus in the industry, many obstacles exist...

logo

4 Ways to ClaimIt: Scenarios for Using Mobile Clinical Trials

We’re in the midst of a technology transformation in healthcare. Robots are performing surgery, visits to the doctor occur online, and medical devices are smarter than ever. Research studies are no different.


logo

Compliance Problems? 5 Ways Digital Tech Can Help

One of the biggest challenges in clinical research is poor compliance. Subjects who dropout, and who therefore do not provide data specific to study endpoints, are wasted money.

logo

BEYONDFITNESS: Know your risk with Dr Carmen Paulin

Find out how you can gauge your risk level of developing chronic diseases with the power of algorithms.


logo

Duke-NUS commercializes discovery for healthy brain development in babies and children

A discovery made at Duke-NUS Medical School (Duke-NUS) has been licensed to a newly launched Singapore-based company, Babynostics Pte Ltd.


logo

Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients

Measurement of blood pressure (BP) for the diagnosis of hypertension and prediction of cardiovascular diseases.

logo

Fatty Liver is becoming the leading cause of liver diseases

If you are concerned about Fatty Liver and NASH, join our community of patients and doctors to better diagnose and understand this disease.


logo

Medview provides better training that results in better physician adoption

An effective solution to provide better training so healthcare professionals deliver better health outcomes to patients.

logo

Fighting Antibiotic Associated Diarrhea

A high quality probiotic product containing high concentration of Lactobacillus acidophilus and L. casei demonstrated to prevent Clostridium difficile infection and diarrhea during antibiotic treatment. The trial coordinated by SPRIM was published in the American Journal of Gastroenterology. A video


logo

100% Online Clinical Trial Platform

ObvioHealth commercializes two suites of software solutions to help healthcare industry players substantiate health claims as well as achieve better visibility on their healthcare professional network.

logo

Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome

Docosahexanoic acid (DHA) is the most abundant omega-3 fatty acid in brain, and, although it is considered essential, deficiency has not been linked to disease.